HEALTHCARE

Market Dynamics: Factors such as the growing prevalence of infectious diseases and genetic disorders, increasing government support for genomics and proteomics research, and continuing technological developments in gel documentation systems are expected to fuel market growth over the forecast period. As claimed by the Centers for Disease Control and Prevention (CDC), nearly 9,272 new cases of tuberculosis were identified in the US in 2016. Given the drivers, the high cost of modern gel documentation systems with advanced technologies and the rising adoption of quantitative polymerase chain reaction (QPCR) may impede the growth of the market during the review period.  As per Market Research Future (MRFR) analysis, the global market for   Gel Documentation Systems Market   is expected to expand substantially over the forecast period. The market held a value of USD 245 million in 2017 and is expected to rise at 3.6% CAGR from 2017 to 2023 (forecast period). Get a Fre...

Market Overview: The global viral vector manufacturing market is expected to exhibit a strong 22.65% CAGR over the forecast period from 2018 to 2023 , according to the latest research report from Market Research Future (MRFR). The report forecasts a valuation of USD 319 million for the market by the end of the 2018-2023 forecast period. In current time, gene therapy is one of the preferred treatment options for most chronic diseases, that involves the insertion of a functional copy of a gene into a defective cell viral vectors and the absence of the appropriate tools are likely to be the key restraints acting against the global Viral Vector Manufacturing Market Analysis over the forecast period. Many companies in the global viral vector manufacturing market are taking steps to counter the difficulties in producing viral vectors and this area is likely to remain a hive of activity in the coming years. This has also resulted in strong growth prospects for companies that can develo...

Neuroprosthetics Market overview: Neuroprosthetics is a discipline that includes neuroscience and engineering to create devices that work on a brain-computer interface. The process includes devices that can substitute damaged motor, sensory, and cognitive modality to enhance better functional experience.As per the latest report by MRFR, the Global Neuroprosthetics Market is anticipated to expand at 12.4% CAGR between 2018 and 2023. The Neuroprosthetics domain refers to a blend of neuroscience and biomedical engineering. Global Neuroprosthetics Market Growth likely to reach a revenue valuation of USD 10.48 billion by the end of the forecast period. Such market growth can be attributed to various factors including increasing prevalence in neural diseases, overactive bladder syndrome, and various chronic disorders such as epilepsy and parkinson's disease . Further, advanced technologies are providing tools that don't need implanting and are minimally invasive, hence, driving ...

Market Overview: The global market for artificial pancreas device system, as described by Market Research Future (MRFR), is showing potential of achieving almost 21.10% CAGR during the forecast period of 2018 to 2023 . In the process, the market is showing promising signs of crossing USD 341.08 million by the end of 2023. In case of type 1 and type 2 diabetes, the pancreas produces little to no insulin which makes it imperative for patients, especially those suffering from type 1diabetes, to inject insulin to regulate their blood glucose levels. This is important to keep complications such as cardiovascular disease, kidney failure, blindness etc. at bay. However, diabetes management involves blood glucose monitoring, insulin dose calculation and insulin infusion with needle or pump. The use of an artificial pancreas device system which continuously monitors blood glucose is often found to be beneficial for many patients. Healthcare regulatory bodies like the U.S. FDA are closely c...

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...

Aptamers Market Trends: Numerous factors are adding to the aptamers market growth. Such factors, as revealed by the latest MRFR report, include increasing use in disease treatment and drug discovery, an increasing number of companies investing in the market, improvement in apatamers development technologies, and proven high diagnostic and therapeutic value of RNA aptamers with current FDA approval for the first-ever aptamers drug.  The Aptamers Market Forecast is likely to grow at a 20.2% CAGR between 2018- 2023 reveals the new Market Research Future (MRFR) report. Aptamers, simply put, are peptide molecules or oligonucleotides which bind to target lipid, proteins, or nucleic acid molecules. They are rapidly generated and applied in specific detection, characterization, and inhibition of proteins. The best part, they are cost-effective and multipurpose that offer antibodies with an alternative or complementary solutions. Get a Free Sample @ https://www.marketresearchfutu...

Market Highlights: The increasing prevalence of Addison’s disease and rising research & development activities to produce new products for diagnosing and treating diseases is expected to drive market growth over the forecast period. According to a report published by the National Center for Biotechnology Information in June 2017, the incidence rate of Addison’s disease is 0.6 per 100,000 of the population per year. Despite the drivers, difficulty in diagnosis in early stages and lack of knowledge can restrain the market growth over the assessment period. Get a Free Sample  @  https://www.marketresearchfuture.com/sample_request/6628 The Global  Addison’s Disease Market  Statistics  is anticipated to hold a market value of USD 168 million in the year 2017 and is expected to grow at a CAGR of 10.4% during the forecast period. Addison’s disease occurs when the body starts producing inadequate amounts of certain hormones produced by adrenal glands. The gl...